Assessing the Effectiveness of Type 2 Diabetes Mellitus Screening in the Republic of Uzbekistan

 Type 2 diabetes mellitus (T2DM) screening should be performed continuously at the primary care level in order to prevent disabling complications. Due to the high prevalence of undiagnosed T2DM in the Republic of Uzbekistan, a decision was made to implement a nationwide screening program aimed at T2DM patients.

 The current study, taking into account the limited resources of Uzbekistan's health care system, aimed to offer the most effective, simple, and economical option required for the actual implementation of regular T2DM screening in the country’s primary care.

 The screening was conducted from December 2018 to March 2019. There were four different scenarios, which differed in terms of eligibility criteria and the methodology adopted for detecting dysglycemia.

 A total of 2,430 patients were examined in four months. The T2DM diagnosis was established by an endocrinologist in 9.3% of the cases with one eligibility criterion and 15.9% of the cases with three eligibility criteria. The diagnosis of T2DM was established by an endocrinologist in 11.7% of the cases with HbA1c screening and 13.5% of the cases with glucose screening.

 The screening was feasible in Uzbekistan only in limited conditions. The reasonable strategy was found to be the screening for incidental glycemia in all patients with at least one T2D risk factor. It was recommended that patients with incidental glycemia ≥ 7.8 mmol/L should be tested for fasting glycemia.